Whitehawk Therapeutics
WHWK3.8500.00% ( 0.000 )
Whitehawk Therapeutics (WHWK)
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It pro...
- Open
- 3.870
- High
- 3.920
- Low
- 3.750
- Prev. Close
- 3.850
- Volume
- 309.83K
- Turnover
- 1.19M
- Avg Price
- 3.848
- Bid/Ask Ratio
- --
- Amplitude
- 4.42%
- 52wk High
- 5.495
- Volume Ratio
- 0.65
- Turnover Ratio
- 1.38%
Whitehawk Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 22, 2026Price forecast
$7.5094.81%
Forecast & RatingBuy
8analysts
- Strong buy50.00%
- Buy12.50%
- Hold37.50%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 22 at 07:40 AM
Akari Therapeutics enters strategic ADC payload research collaboration with Whitehawk Therapeutics
- GlobeNewswire · Jul 22 at 07:40 AM
Akari Therapeutics CEO Explains Why Growing Industry Demand for Next-Generation ADC Payloads Positions the Company at the Center of a Major Oncology Opportunity
- StockTitan · Jul 20 at 10:05 PM
Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics | AKTX Stock News
- Market Beat · Jul 14 at 05:40 AM
Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Sees Large Increase in Short Interest
- Pharmaceutical Technology · Jul 8 at 02:59 AM
Biocytogen and Whitehawk partner to develop ADCs
- PUBT · Jul 7 at 07:07 AM
Biocytogen, Whitehawk Therapeutics team up on bispecific antibody-drug conjugate development
